Anti-inflammatory agents such as interleukin (IL)-1 receptor antagonists and neutralizing antibodies against tumor necrosis factor (TNF) have been shown to be efficacious for the treatment of an animal model of sepsis [4,5]. This evidence concerns the gene TNF and Sepsis.